Quiz: Current Therapeutic Approaches for Neovascular AMD
The clinical hallmark of nAMD is:
Which of the following is not an anti-VEGF agents currently approved for the treatment of nAMD?
Future studies on anti-VEGF agents for the treatment of nAMD aim to:
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809